Topics in This Article

The Code of Federal Regulations 21 CFR Part 11 defines how electronic records and electronic signatures must be managed so the FDA accepts them as equivalent to paper and handwritten signatures. Any life sciences company using computerized systems for GxP data must understand and implement 21 CFR Part 11 compliance to avoid findings, warning letters, or rejected submissions.

This guide explains what CFR Part 11 is, which organizations it applies to, key requirements of 21 CFR Part 11, and practical steps to reach and maintain CFR compliance.

What Is Code of Federal Regulations 21 CFR Part 11?

Title 21 CFR Part 11 is an FDA regulation that sets the criteria under which electronic records (ERs) and electronic signatures (ESs) are considered trustworthy, reliable, and equivalent to paper records and handwritten signatures. It applies to records created, modified, maintained, archived, retrieved, or transmitted under any FDA predicate rules (such as GMP, GCP, or GLP).

In practice, Part 11 enables fully digital GxP processes—batch records, lab data, quality documents, and clinical data—provided that organizations implement defined technical and procedural controls. The regulation is technology‑neutral and focuses on outcomes: data integrity, security, and traceability of regulated records.

Who Must Comply With CFR Part 11?

CFR Part 11 compliance is mandatory for organizations that submit or maintain FDA‑regulated records in electronic form or use electronic signatures in place of handwritten signatures. This includes pharmaceutical and biopharmaceutical companies, medical device and IVD manufacturers, biotechnology firms, CROs, clinical sites, and contract manufacturers handling FDA‑regulated products.

Vendors cannot “certify” software as compliant; responsibility for 21 CFR Part 11 compliance always rests with the regulated company, which must combine appropriate software features with robust procedures and validation. Even when systems are not used to submit data directly to FDA, Part 11 may still apply if records support GxP activities or regulatory decisions.

Core Requirements Of 21 CFR Part 11

The requirements of 21 CFR Part 11 can be grouped into several core pillars: system validation, electronic records controls, audit trails, security and access control, and electronic signatures. Together, these controls ensure that records are accurate, complete, protected, and attributable to specific individuals.

Key elements include validation to ensure accuracy and reliability, the ability to generate accurate copies of records, protection of records throughout their retention period, and secure, computer‑generated audit trails. Additional requirements cover authority checks, device checks, operational checks, training, policies for accountability, and stringent controls around electronic signatures to prevent repudiation.

System Validation

Systems used to create, modify, maintain, archive, retrieve, or transmit electronic records must be validated to ensure consistent, intended performance. Validation must be documented and risk‑based, covering software functionality, infrastructure, interfaces, and data flows relevant to GxP use.

A typical validation approach includes a validation plan, user requirements, functional specifications, risk assessment, test protocols (IQ/OQ/PQ), traceability matrix, and final validation report. Ongoing change control and periodic review are required so that validated status is maintained as systems, configurations, or use cases evolve.

Part 11 requires that organizations can generate accurate and complete copies of electronic records in both human readable and electronic form for inspection, review, and copying by the FDA. Records must be protected to enable accurate and ready retrieval throughout their retention period, including backup, disaster recovery, and protection against unauthorized alteration.

Systems must enforce operational checks to ensure that steps and events occur in the proper sequence, plus device checks to validate the authenticity of data sources and input devices. Procedures must define how records are created, maintained, archived, and disposed of, ensuring integrity from initial entry through final retention.

Closed and open systems must employ secure, computer‑generated, time‑stamped audit trails that independently record the date and time of operator entries and actions that create, modify, or delete electronic records. Audit trails must preserve prior values so changes are fully reconstructable and must be retained as long as the associated records.

Good 21 CFR Part 11 compliance practice also emphasizes ALCOA+ data integrity principles—data should be attributable, legible, contemporaneous, original, and accurate, plus complete, consistent, enduring, and available. To support this, systems commonly enforce unique user IDs, strict permissions, batch or sample traceability, and controlled workflows that reduce opportunities for manipulation.

Part 11 requires limiting system access to authorized individuals using robust access controls such as unique logins, password policies, and role‑based permissions. Controls must prevent unauthorized use of user accounts and provide accountability for actions taken under each user’s credentials.

Organizations must also ensure that personnel who develop, maintain, or use electronic systems have appropriate education, training, and experience and must maintain training records. Written policies must hold individuals accountable for actions initiated under their electronic signatures and regulate the use of passwords and tokens.

Electronic signatures may be used in place of handwritten signatures only if they are unique to one individual and not reused by or reassigned to others. Before assigning electronic signature credentials, organizations must verify the identity of the individual whose signature they represent.

Each signed electronic record must clearly show the printed name of the signer, the date and time when the signature was executed, and the meaning of the signature (such as “reviewed,” “approved,” or “verified”). Part 11 also requires that electronic signatures be linked to their respective electronic records in a way that prevents the signatures from being excised, copied, or transferred to falsify a record.

CFR Part 11 Compliance vs CFR Compliance Generally

CFR compliance broadly refers to adherence to relevant parts of the U.S. Code of Federal Regulations, such as GMP (21 CFR Parts 210–211), GCP, GLP, or medical device regulations. 21 CFR Part 11 compliance is a specific subset focused on how electronic records and signatures are managed in the context of those underlying predicate rules.

Regulated organizations must first ensure compliance with predicate rules for product quality and safety and then apply Part 11 controls to the electronic records generated under those rules. In other words, Part 11 does not stand alone; it overlays and supports existing regulatory requirements by defining when electronic documentation is acceptable.

Adhering to the Code of Federal Regulations 21 CFR Part 11 is crucial for business compliance

Key Focus Areas: CFR Part 11 vs General GxP

Aspect 21 CFR Part 11 Focus General GxP / CFR Focus
Primary objective Trustworthy electronic records and signatures. Product quality, patient safety, and efficacy.
Scope Systems and processes using ER/ES for regulated activities. Entire product lifecycle from development to post-market.
Core controls Validation, audit trails, access, e-signatures, data integrity. Manufacturing controls, testing, documentation, CAPA, complaints.
Evidence expected by regulators Technical and procedural controls proving ER/ES reliability. Batch records, lab data, clinical evidence, quality system records.

Best Practices To Achieve 21 CFR Part 11 Compliance

Achieving and sustaining CFR Part 11 compliance requires a combination of risk‑based governance, validated technology, and clear procedures. A structured roadmap helps organizations build compliant, audit‑ready environments without over‑engineering controls for low‑risk systems.

Key best practices include:

  • Conducting a Part 11 applicability and risk assessment across all systems that store or manage GxP data.
  • Selecting platforms that provide native support for audit trails, e‑signatures, permission management, and secure record storage.
  • Implementing formal validation, change control, and periodic review to maintain the validated state.
  • Establishing SOPs covering electronic records management, security, incident handling, backup/restore, and signature use.
  • Training users on data integrity, correct use of electronic signatures, and accountability expectations.

Modern cloud solutions, including asset and maintenance management platforms, often come with features like detailed audit trails, restricted access, and workflow controls that significantly ease the path to compliance when combined with robust implementation and validation.

How Timly Can Support 21 CFR Part 11 Compliance

For organizations managing GxP‑relevant equipment, tools, or assets, a digital asset tracking and maintenance platform can be an important enabler for CFR Part 11 compliance. Such a system helps centralize equipment data, calibration records, and maintenance histories in a structured, tamper‑resistant way.

When evaluating a solution like Timly for use in regulated environments, quality and IT teams typically look for capabilities such as role‑based access control, documented change histories, and the ability to export records in human‑readable formats for inspections. Combined with proper validation and SOPs, this type of platform can strengthen data integrity around assets that directly affect product quality and support audit readiness for FDA and other authorities.

Conclusion: Building Sustainable CFR Part 11 Compliance

Implementing 21 CFR Part 11 compliance is ultimately about creating an environment where electronic records and signatures can be trusted as much as paper, both by regulators and by the organization itself. By focusing on validated systems, strong access control, robust audit trails, and well‑governed electronic signatures, companies can digitize their processes without sacrificing regulatory confidence.

As GxP processes become more data‑driven and distributed, organizations that invest early in compliant digital platforms—backed by sound governance and training—will find it easier to scale operations and pass FDA inspections. Solutions such as Timly can contribute to this foundation by enhancing control and transparency over critical assets and their associated records in a Part 11‑aligned way.

FAQs About Code of Federal Regulations 21 CFR Part 11

The main purpose of 21 CFR Part 11 is to define when electronic records and electronic signatures can be considered trustworthy, reliable, and equivalent to paper records and handwritten signatures for FDA‑regulated activities.

Key requirements include system validation, secure and complete electronic records, computer‑generated audit trails, access controls, training and policies for accountability, and stringent controls for unique and verifiable electronic signatures.

Only software used to create, modify, maintain, archive, retrieve, or transmit electronic records that fall under FDA predicate rules, or that apply electronic signatures in place of handwritten signatures, needs to be compliant with applicable Part 11 provisions.